The UKCCCR trial of the frequency of breast cancer screening is published in this
issue and is accompanied by a commentary from Dr Ingvar Andersson.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The design and clinical use of the Nottingham Prognostic Index in breast cancer.The Breast. 1996; 5: 156-157
- The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).Breast Cancer Res & Treat. 1994; 32: 281-290
- Incidence and prognosis in early onset breast cancer.The Breast. 2002; 11: 30-35
- Prognostic factors in breast cancer.Eur. J. Cancer. 2001; 37: 591-596
Article info
Publication history
Accepted:
April 29,
2002
Received:
April 11,
2002
Identification
Copyright
© 2002 Elsevier Science Ltd. Published by Elsevier Inc. All rights reserved.
